More
    HomeAsian technologyHigh Growth Tech Stocks in Asia for July 2025

    High Growth Tech Stocks in Asia for July 2025

    Published on

    The Asian tech sector is navigating a dynamic landscape, with regional markets reflecting a mix of resilience and cautious optimism amid ongoing global trade discussions and fluctuating economic indicators. As investors seek opportunities in high-growth tech stocks, it’s crucial to consider companies that demonstrate strong innovation potential, adaptability to changing market conditions, and robust financial health.

    Name

    Revenue Growth

    Earnings Growth

    Growth Rating

    Fositek

    28.74%

    35.42%

    ★★★★★★

    Shanghai Huace Navigation Technology

    24.44%

    23.48%

    ★★★★★★

    Shengyi Electronics

    22.99%

    35.16%

    ★★★★★★

    Range Intelligent Computing Technology Group

    27.31%

    28.63%

    ★★★★★★

    eWeLLLtd

    24.95%

    24.40%

    ★★★★★★

    PharmaResearch

    25.04%

    26.89%

    ★★★★★★

    Global Security Experts

    20.56%

    28.04%

    ★★★★★★

    Marketingforce Management

    26.39%

    112.30%

    ★★★★★★

    CARsgen Therapeutics Holdings

    81.05%

    87.21%

    ★★★★★★

    JNTC

    55.45%

    94.52%

    ★★★★★★

    Click here to see the full list of 489 stocks from our Asian High Growth Tech and AI Stocks screener.

    Here we highlight a subset of our preferred stocks from the screener.

    Simply Wall St Growth Rating: ★★★★★★

    Overview: ALTEOGEN Inc. is a biotechnology company specializing in the development of long-acting biobetters, proprietary antibody-drug conjugates, and antibody biosimilars, with a market capitalization of ₩21.27 billion.

    Operations: The company generates revenue primarily from its biotechnology segment, amounting to ₩151.65 million. The business focuses on innovative biopharmaceutical products, including long-acting biobetters and antibody-drug conjugates.

    ALTEOGEN has demonstrated a robust trajectory in the biotech sector, with earnings surging by 387.3% over the past year, significantly outpacing the industry growth of 47.8%. This performance is underpinned by an aggressive R&D strategy, crucial for maintaining its edge in a highly competitive market. With revenue and earnings forecasted to grow annually at 52.3% and 65.2% respectively, ALTEOGEN is not just keeping pace but setting benchmarks within Asia’s high-growth tech landscape. The firm’s strategic focus on innovative biotechnologies positions it well amid evolving industry demands, while a forecasted Return on Equity of 76.4% signals strong managerial efficacy and potential future gains.

    KOSDAQ:A196170 Revenue and Expenses Breakdown as at Jul 2025

    Simply Wall St Growth Rating: ★★★★☆☆

    Overview: Lens Technology Co., Ltd. focuses on the R&D, production, and sale of structural parts, functional modules, and complete machine assemblies in China with a market cap of CN¥120.16 billion.

    Source link

    Latest articles

    American And Chinese Energy Policies: Great Minds Think Alike

    Global trends have shifted in the past few years and as I’ve already discussed,...

    Strategic Contracts and R&D Fueling Sustainable Growth

    Asia's tech sector is poised for a strong Q3 2025,...

    High Growth Tech Stocks in Asia To Explore This July 2025

    As global markets experience varied performances, with the...

    More like this